Back to DE D. E. Shaw & Co., Inc.
CUE
Showing 0 of 4 quarters
Position history for DED. E. Shaw & Co., Inc.'s holdings in CUE BIOPHARMA INC
No. D. E. Shaw exited its CUE (Cue Biopharma) position in Q3 2023. Its Q2 2023 13F listed 36,681 shares worth $133,886. D. E. Shaw first reported CUE in Q4 2019 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.